I have Type 1 diabetes. I love to write. I’m happy when I am helping others. I speak up when it’s important. I have a passion for sharing knowledge and learning new technology. I was BORN to BLOG!

I’ve met so many other T1Ds on this journey who are cool and love to help others. We put our heads and hearts together … to bring more resources and knowledge to our amazing diabetes community. We’re making improvements every day … come back often, let us know what you think. And my gratitude for my amazing webmaster, Dave (an honorary T1D)!

And thank you for stopping by!
— Joanne Laufer Milo, The Savvy Diabetic

Savvy Updates 1/16/23: CGM $$$, Insulin Pill Fails, Med School & AI, DIY Loop 3.0, 5-Minute Walks, T1D Kids & School Days

Savvy Updates 1/16/23: CGM $$$, Insulin Pill Fails, Med School & AI, DIY Loop 3.0, 5-Minute Walks, T1D Kids & School Days

CGM is BIG MONEY!!! How Abbott plans to make its Freestyle Libre a $10B product by Elise Reuter for MedTechDive.com, 10 January 2023.  CEO Robert Ford discussed plans to grow the market for Abbott’s continuous glucose monitors and its broader diabetes...

read more
Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App

Savvy Updates, 1/9/22: Beta Bionics NEW CMO, EoFlow Patch Pump Submits to FDA, Fruits/Veggies App, How Ozempic/Wegovy Work, Drug Makers Raise Prices 2023, Happy Bob App

Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System in a press release on NewsWire.com, 4 January 2023.  Caution: The iLet Bionic Pancreas is an investigational device...

read more
Savvy Updates, 1/2/23:  Ozempic Shortages, Artificially Sweetened Drinks & Incontinence, Worldwide Surge in Diabetes, FDA Regulating Practice of Medicine, Happy New Year

Savvy Updates, 1/2/23: Ozempic Shortages, Artificially Sweetened Drinks & Incontinence, Worldwide Surge in Diabetes, FDA Regulating Practice of Medicine, Happy New Year

Novo Nordisk addresses off-label Ozempic use as it grapples with multiple shortages by Nicole DeFeudis for EndPoints.com, 13 December 2022. On the heels of Wegovy supply troubles, Novo Nordisk is reporting a shortage of its diabetes treatment Ozempic which contains...

read more
Savvy Foods/Eating, 12/21/22: Eating Chocolate Daily, Gut Bacteria Affects Exercise Motivation, Aspartame & Anxiety, Dark Chocolate Dangers

Savvy Foods/Eating, 12/21/22: Eating Chocolate Daily, Gut Bacteria Affects Exercise Motivation, Aspartame & Anxiety, Dark Chocolate Dangers

What Happens to Your Body When You Eat Chocolate Every Day by Isabel Vasquez for EatingWell.com, 4 December 2022. If you're a chocolate lover, you may feel confused about whether eating it is beneficial or detrimental to your health. As you know, chocolate has various...

read more
Savvy Updates 12/19/22:  Tandem Buys Sigi Patch Pump, Lilly Quits Deal with Ypsomed, Mallya Smart Sensor for Insulin Pens, Dexcom G7 with Jake Leach, Lilly & Sosei $37M Research Contract, Insulin-Mimicking Molecule, More on Dex G7

Savvy Updates 12/19/22: Tandem Buys Sigi Patch Pump, Lilly Quits Deal with Ypsomed, Mallya Smart Sensor for Insulin Pens, Dexcom G7 with Jake Leach, Lilly & Sosei $37M Research Contract, Insulin-Mimicking Molecule, More on Dex G7

Tandem agrees to buy AMF, challenging Insulet for insulin pump patch market by Nick Paul Taylor for MedTechDive.com, 14 December 2022.   Tandem Diabetes Care agreed to acquire Switzerland-based AMF Medical to gain its insulin pump patch technology. Tandem...

read more
Savvy Updates, 12/9/22:  Dexcom G7 APPROVED, Libre3 vs G7 Face Off, Lilly’s Mounjaro, Time In Range Essential, CVS Sued for Fraud to ADA, Nurses in Diabetes Care, Call Your Doctor by First Name?

Savvy Updates, 12/9/22: Dexcom G7 APPROVED, Libre3 vs G7 Face Off, Lilly’s Mounjaro, Time In Range Essential, CVS Sued for Fraud to ADA, Nurses in Diabetes Care, Call Your Doctor by First Name?

Dexcom G7 CGM System Receives FDA Clearance posted on EndocrinologyNetwork.com, 8 December 2022. Dexcom has announced their Dexcom G7 Continuous Glucose Monitoring (CGM) system has received clearance from the US Food and Drug Administration for people with all types...

read more
Savvy Updates, 12/5/22:  Ypsomed MyLife Loop, Insulin Resistance & CVD & Depression, HearO App Predicts Heart Failure, Biscuits, Low Carb Grilled Feta, Cows Wearing Trackers

Savvy Updates, 12/5/22: Ypsomed MyLife Loop, Insulin Resistance & CVD & Depression, HearO App Predicts Heart Failure, Biscuits, Low Carb Grilled Feta, Cows Wearing Trackers

Ypsomed, CamDiab launch first automated insulin dosing system with Abbott FreeStyle Libre 3 was reported by Sean Whooley for DrugDeliveryBusiness.com, 28 November 2022. Ypsomed announced that its mylife Loop now has authorization to work with the Abbott...

read more
Savvy Updates, 11/28/22:  Wearable/Stretchable Tracking Devices, iTolerance Tech Without Immunosuppression, PBM Reform HIGH Priority, Allulose, W!LD Winter 2022

Savvy Updates, 11/28/22: Wearable/Stretchable Tracking Devices, iTolerance Tech Without Immunosuppression, PBM Reform HIGH Priority, Allulose, W!LD Winter 2022

How wearable devices with skin-like stretchability may pave way for better health tracking was reported by Nick Paul Taylor for MedTechDive.com, 21 November 2022. The DOE’s Argonne National Laboratory teamed up with the University of Chicago’s Pritzker School of...

read more
Savvy Updates, 11/21/22:  Insulet Omnipod 5 Controller Recall, Provention Bio’s Teplizumab (Tzield), Rezvoglar Biosimilar, Sugar Alcohols, Stevia, Veggies & Rock Music

Savvy Updates, 11/21/22: Insulet Omnipod 5 Controller Recall, Provention Bio’s Teplizumab (Tzield), Rezvoglar Biosimilar, Sugar Alcohols, Stevia, Veggies & Rock Music

Insulet Issues a Nationwide Voluntary Medical Device Correction for the Omnipod 5 Controller  Insulet Corporation announced a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an issue with the Omnipod 5 Controller charging...

read more
Share This
Skip to content